Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending July 1
McDonald’s, Dollar Tree, GoFundMe, Stride, Otis, Intrusion, Monogram Health, Mass Luminosity
By
Lauren Muskett
| July 1, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Eli Lilly
People
CFOs On the Move: Week Ending February 12
Eli Lilly, Pilgrim’s Pride, Belden, Goodwill, Taco John’s, Weee, The Conrad N. Hilton Foundation, Lids, Sema4
By
Lauren Muskett
| February 12, 2021
Read More
M&A
Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology
In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.
By
William Sprouse
| January 7, 2019
Read More
IPOs
Lilly’s Elanco Expects IPO to Raise $1.4B
The animal health spinoff is the second major industry player to go public, following Zoetis' successful offering.
By
Matthew Heller
| September 6, 2018
Read More
Corporate Finance
Eli Lilly to Spin Off Animal-Health Business
Eli Lilly reported a quarterly loss of $260 million and announced plans for an IPO of Elanco by the end of 2018.
By
William Sprouse
| July 24, 2018
Read More
People
CFOs on the Move: Week Ending Oct. 6
Eli Lilly, Mattel, Georgia Power, Pier 1 Imports, Bravo Brio Restaurant Group, Purchasing Power,, White Energy
By
Joan Urdang
| October 6, 2017
Read More
People
Lilly Veteran Josh Smiley Promoted to CFO
Smiley takes over from Derica Rice amid a cost-cutting push aimed at freeing up cash for Lilly to invest in developing new drugs.
By
Matthew Heller
| October 2, 2017
Read More
Strategy
Eli Lilly to Trim 3,500 Jobs to Save $500 Million
The drugmaker is seeking to become "a leaner, more nimble global organization" as it invests in a new generation of medicines.
By
Matthew Heller
| September 7, 2017
Read More
People
CFOs on the Move: Week Ending June 3
Uber, Eli Lilly, Occidental Petroleum, Dunkin' Brands, Cloudflare, American Express Business Travel, Neiman Marcus, Proterra, Knoll, Tivity Health
By
David McCann
| June 2, 2017
Read More
Financial Performance
New Products Fuel Eli Lilly Q1 Earnings Beat
Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."
By
Matthew Heller
| April 26, 2017
Read More
Strategy
Lilly Buys Vetmedica Pet Vaccines for $885M
The deal will diversify Lilly's Elanco animal medicine business, adding vaccines for rabies and other feline and canine illnesses.
By
Matthew Heller
| October 5, 2016
Read More
M&A
The Prescription for Pharma Is Revenue Growth
Despite the hullabaloo about health-care reform, investors still reward revenue growth by pharmaceutical companies. But that growth requires organic and acquisitive reinvestment.
By
Gregory V. Milano and John R. Cryan
| April 4, 2012
Read More